MEF2C Mouse Monoclonal Antibody [Clone ID: OTI4F7]

CAT#: TA502628

MEF2C mouse monoclonal antibody, clone OTI4F7 (formerly 4F7)

Size: 30 ul 100 ul

Formulation: Standard Carrier Free


  View other "OTI4F7" antibodies (3)

USD 379.00

In Stock*

Size
    • 100 ul

Other products for "MEF2C"

Specifications

Product Data
Clone Name OTI4F7
Applications FC, IF, IHC, WB
Recommended Dilution WB 1:2000, IHC 1:150, IF 1:100, FLOW 1:100
Reactivities Human, Mouse, Rat
Host Mouse
Isotype IgG2a
Clonality Monoclonal
Immunogen Full length human recombinant protein of human MEF2C (NP_002388) produced in HEK293T cell.
Formulation PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Store at -20°C as received.
Stability Stable for 12 months from date of receipt.
Predicted Protein Size 51 kDa
Gene Name myocyte enhancer factor 2C
Background This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe mental retardation, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq]
Synonyms C5DELq14.3; DEL5q14.3
Reference Data
Protein Families Transcription Factors
Protein Pathways MAPK signaling pathway

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.